Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma

Monoamine oxidase inhibitors (MAOIs) are an important class of drugs prescribed for treatment of depression and other neurological disorders. Evidence has suggested that patients with atypical depression preferentially respond to natural product MAOIs. This review presents a comprehensive survey of...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Molecules
المؤلفون الرئيسيون:	Narayan D. Chaurasiya, Francisco Leon, Ilias Muhammad, Babu L. Tekwani
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2022-07-01
الموضوعات:	natural products monoamine oxidases (MAO-A and -B) antidepressant monoamine oxidase inhibitors neurological disorders neuroprotection
الوصول للمادة أونلاين:	https://www.mdpi.com/1420-3049/27/13/4297